Reply to letter to the editor 'Primum non nocere' by Templeton and Šeruga
- PMID: 26153497
- DOI: 10.1093/annonc/mdv294
Reply to letter to the editor 'Primum non nocere' by Templeton and Šeruga
Comment on
-
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis.Ann Oncol. 2015 Apr;26(4):688-695. doi: 10.1093/annonc/mdu579. Epub 2014 Dec 26. Ann Oncol. 2015. PMID: 25542926
-
Primum non nocere.Ann Oncol. 2015 Oct;26(10):2197-8. doi: 10.1093/annonc/mdv291. Epub 2015 Jul 13. Ann Oncol. 2015. PMID: 26169770 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical